Marcello Tiseo

University of Parma

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Massimo Corradi

University of Parma

ITALY

View details

LUCA MORELLI

Professore Associato in Chirurgia Generale

University of Pisa

ITALY

View details

Silvia La Monica

University of Parma

ITALY

View details

Pellegrino Crafa

University of Parma

ITALY

View details

Rosanna Piccirillo

Head of the Neuromuscular Disfunctions Laboratory

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Alessandro Leonetti

ITALY

View details

Paolo Spagnolo

University of Padova

ITALY

View details

Andrea Cavazzoni

Assistant professor

University of Parma

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marcello Tiseo

Research Interests

Explore related searches

Contact this professor

Articles (10)

Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion

Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics

CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial

Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma

Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring <i>BRAF</i> Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups

Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature

Collaborators (8)

Massimo Corradi

LUCA MORELLI

Silvia La Monica

Pellegrino Crafa

Rosanna Piccirillo

Alessandro Leonetti

Paolo Spagnolo

Andrea Cavazzoni

Make your next move.